Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  European Urology

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.eururo.2017.12.018PMID 29325693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population.

  2017cited by this paper
• UICC drops the ball in the 8th edition TNM staging of urological cancers

  2017cited by this paper
• Subclassification of pN3 staging systems for penile cancer: Proposal for modification of the current TNM classification.

  2017cited by this paper
• The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging

  2017cited by this paper
• Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.

  2017cited by this paper
• Reporting and Staging of Testicular Germ Cell Tumors: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations.

  2017cited by this paper
• Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

  2017cited by this paper
• Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: Comparison and Ranking of T1 Quantification Approaches to Predict Progression to Muscularis Propria Invasion

  2017cited by this paper
• EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

  2017cited by this paper
• Prostate cancer – major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

  2017cited by this paper
• Independent Validation of the American Joint Committee on Cancer 8th Edition Prostate Cancer Staging Classification

  2017cited by this paper
• The World Health Organization 2016 classification of testicular non‐germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel

  2017cited by this paper
• The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel

  2017cited by this paper
• Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading

  2017cited by this paper
• American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine

  2016cited by this paper
• Modification of the pT2 substage classification in prostate adenocarcinoma.

  2016cited by this paper
• Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis.

  2016cited by this paper
• WHO Classification of of Tumours of the Urinary System and Male Genital Organs

  2016cited by this paper
• A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.

  2016cited by this paper
• Guidelines on Testicular Cancer: 2015 Update.

  2015cited by this paper
• Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy

  2015cited by this paper
• EAU guidelines on penile cancer: 2014 update.

  2015cited by this paper
• Modification of N staging systems for penile cancer: a more precise prediction of prognosis

  2015cited by this paper
• Development and external validation of a prognostic tool for prediction of cancer‐specific mortality after complete loco‐regional pathological staging for squamous cell carcinoma of the penis

  2015cited by this paper
• Modification of N staging systems for penile cancer: a more precise prediction of prognosis

  2015cited by this paper
• Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists

  2015cited by this paper
• The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System

  2015cited by this paper
• Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy

  2014cited by this paper
• Rhabdoid Differentiation Is Associated With Aggressive Behavior in Renal Cell Carcinoma: A Clinicopathologic Analysis of 76 Cases With Clinical Follow-up

  2014cited by this paper
• Significance of perivesical lymph nodes in radical cystectomy for bladder cancer.

  2014cited by this paper
• Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance

  2014cited by this paper
• Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).

  2014cited by this paper
• Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer.

  2014cited by this paper
• NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines

  2014cited by this paper
• Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin‐based chemotherapy

  2013cited by this paper
• Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma.

  2013cited by this paper
• Penile cancer: Clinical Practice Guidelines in Oncology.

  2013cited by this paper
• Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy.

  2013cited by this paper
• The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

  2013cited by this paper
• Testicular hilum and vascular invasion predict advanced clinical stage in nonseminomatous germ cell tumors

  2013cited by this paper
• Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy.

  2013cited by this paper
• Handling and Staging of Renal Cell Carcinoma: The International Society of Urological Pathology Consensus (ISUP) Conference Recommendations

  2013cited by this paper
• A new and highly prognostic system to discern T1 bladder cancer substage.

  2012cited by this paper
• Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma.

  2011cited by this paper
• International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease

  2011cited by this paper
• Limited smoothelin expression within the muscularis mucosae: validation in bladder diverticula.

  2011cited by this paper
• International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling

  2011cited by this paper
• Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.

  2011cited by this paper
• International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes

  2011cited by this paper
• International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins

  2011cited by this paper
• New N staging system of penile cancer provides a better reflection of prognosis.

  2011cited by this paper
• International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume

  2010cited by this paper
• Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.

  2010cited by this paper
• Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients

  2010cited by this paper
• Rete testis invasion by malignant germ cell tumor and/or intratubular germ cell neoplasia: what is the significance of this finding?

  2010cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Histopathologic features and clinical outcomes in 71 cases of bladder diverticula.

  2009cited by this paper
• Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53.

  2009cited by this paper
• Comparison of Morphologic Features and Outcome of Resected Recurrent and Nonrecurrent Squamous Cell Carcinoma of the Penis: A Study of 81 Cases

  2009cited by this paper
• Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy.

  2009cited by this paper
• Evaluation of current TNM classification of penile carcinoma.

  2008cited by this paper
• Histologic Grade and Perineural Invasion are More Important Than Tumor Thickness as Predictor of Nodal Metastasis in Penile Squamous Cell Carcinoma Invading 5 to 10 mm

  2008cited by this paper
• Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.

  2007cited by this paper
• Renal Cell Carcinoma and the Renal Sinus

  2007cited by this paper
• Renal veins and venous extension in clear cell renal cell carcinoma

  2007cited by this paper
• The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy.

  2006cited by this paper
• Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.

  2006cited by this paper
• Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

  2005cited by this paper
• A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation.

  2005cited by this paper
• Sarcomatoid Carcinoma of the Penis: A Clinicopathologic Study of 15 Cases

  2005cited by this paper
• Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma

  2004cited by this paper
• Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases.

  2003cited by this paper
• The prognostic significance of metastatic perivesical lymph nodes identified in radical cystectomy specimens for transitional cell carcinoma of the bladder.

  2003cited by this paper
• Carcinoma in a bladder diverticulum: presentation and treatment outcome.

  2003cited by this paper
• Adult rhabdoid renal cell carcinoma.

  2002cited by this paper
• Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer.

  2002cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled Analysis

  2002cited by this paper
• Adult Rhabdoid Renal Cell Carcinoma Divergent Differentiation of Conventional (Clear Cell) Carcinoma

  2002cited by this paper
• Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer.

  2001cited by this paper
• Renal cell carcinoma with rhabdoid features.

  2000cited by this paper
• Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy.

  1999cited by this paper
• Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.

  1999cited by this paper
• Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement.

  1996cited by this paper
• Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.

  1996cited by this paper
• SQUAMOUS‐CELL EPITHELIOMA OF THE SKIN A STUDY OF 256 CASES

  1921cited by this paper

• Statistical and Computational Paradigms in Cancer Staging, Grading and Prognosis: A Comprehensive Review

  2026cites this paper
• In Regard to Ka et al.

  2026cites this paper
• Avoiding unnecessary biopsy in suspicious prostate cancer using PRIMARY score ≤3 and PSAD ≤0.2 ng/mL/cm3: a real-world, dual-center study from China.

  2026cites this paper
• Optimizing pelvic lymph node dissection in bladder cancer: obturator focus, pN1 prognosis, and sentinel node feasibility

  2026influential citation
• Surgical Management of Nonmetastatic Renal Cell Carcinoma with Inferior Vena Cava Thrombus: A Systematic Review and Network Meta-analysis.

  2026cites this paper
• Fluorescent Ureterorenoscopy-Assisted Thulium:YAG and Holmium:YAG Dual-Laser Ablation for Upper Urinary Tract Urothelial Carcinoma: Results of the FLUAM Trial.

  2026cites this paper
• Partial nephrectomy for clinical T2b, T3a, and T3b renal mass: evaluating trifecta achievement and surgical outcomes

  2026cites this paper
• Integrated single-cell and spatial transcriptomics combined with whole-exome sequencing reveal key hub genes and epithelial heterogeneity in bladder cancer

  2026cites this paper
• Restage Transurethral Resection in the Evaluation of T1 High-Grade Bladder Tumor

  2026cites this paper
• Renal Cell Carcinoma in Native Kidney After Kidney Transplantation: A Multicenter Case Control Study With a Focus on Screening Strategy

  2025cites this paper
• A modified ureteroileal anastomosis can reduce the incidence of ureteroileal anastomotic stricture

  2025cites this paper
• Diagnostic and prognostic role of 18F-FDG PET/CT for sarcomatoid differentiation in renal cell carcinoma

  2025cites this paper
• The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Glandular Lesions of the Urinary Bladder.

  2025cites this paper
• Prognostic Value of the Extent of Lymphadenectomy for Overall Survival Among Patients with Non-muscle Invasive Bladder Cancer, A Retrospective Cohort Study

  2025cites this paper
• MRI for Prostate Cancer Local Staging: AJR Expert Panel Narrative Review.

  2025cites this paper
• Clinical features and therapeutic experiences of renal cancer related to Xp11.2 translocation/TFE3 gene fusion: A case series of 18 patients.

  2025cites this paper
• Clear Cell Renal Cell Carcinoma Metastasis to the Thyroid: A Narrative Review of the Literature

  2025cites this paper
• Identifying myosin heavy chain 11 as a predictive biomarker of prostate cancer progression and antiandrogen resistance

  2025cites this paper
• TROP-2 Promotes Cell Proliferation via the AKT-Mediated PKCα Pathway and Is a Novel Target for Antibody-Drug Conjugates in Penile Carcinoma

  2025cites this paper
• Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen–Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial

  2025cites this paper
• An interpretable machine learning model based on CT imaging for predicting lymphovascular invasion and survival in bladder urothelial carcinoma: a multicenter study

  2025cites this paper
• The real prevalence and clinical courses of non-metastatic castration-resistant prostate cancer: a retrospective single-institutional study.

  2025cites this paper
• Comparative Outcomes of Surgery and Chemoradiotherapy After Neoadjuvant Chemotherapy in Stage II–III Bladder Cancer

  2025cites this paper
• Clinical Implications of Upregulated RSAD2 Gene Expression in Hepatocellular Carcinoma

  2025cites this paper
• Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma in the setting of clinical node positive disease: analysis of the ROBUUST registry

  2025cites this paper
• Efficacy of [18F]PSMA-1007 PET/CT in Primary Staging of Prostate Carcinoma: A Systematic Review and Metaanalysis

  2025cites this paper
• Contrast‐enhanced ultrasound enables precision diagnosis of preoperative muscle invasion in bladder cancer: a prospective study

  2025cites this paper
• [Robot-assisted laparoscopic inferior vena cava segmental resection for renal tumor with tumor thrombus invading the vascular wall].

  2025cites this paper
• Risk Stratification for the Prognosis of Patients With pT3aN0M0 Clear Cell Renal Cell Carcinoma.

  2025cites this paper
• Copper death combination therapy: the innovative frontier and challenges in prostate cancer treatment

  2025cites this paper
• Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022 classification

  2025cites this paper
• Effects of targeted therapy for RCC on LUTS in elderly male patients

  2025cites this paper
• Trends in the use and efficacy of adjuvant immunotherapy in muscle-invasive urothelial carcinoma

  2025cites this paper
• Transurethral resection of ureteral tumors at the intramural segment: A pilot study

  2025cites this paper
• Comparative analysis of oncologic outcomes in surgically treated patients with renal cell carcinoma and renal vein thrombosis by pathologic subtypes

  2025cites this paper
• Automatic recognition of surgical phase of robot-assisted radical prostatectomy based on artificial intelligence deep-learning model and its application in surgical skill evaluation: a joint study of 18 medical education centers

  2025cites this paper
• Impact of perirenal collateral on the surgical management and prognosis of nonmetastatic renal cell carcinoma and inferior vena cava tumor thrombus

  2025cites this paper
• An interpretable CT-based deep learning model for predicting overall survival in patients with bladder cancer: a multicenter study

  2025cites this paper
• Large Language Model and Knowledge Graph-Driven AJCC Staging of Prostate Cancer Using Pathology Reports

  2025cites this paper
• Analysis of treatment options and survival outcomes for patients with localized prostate cancer: a focus on androgen deprivation therapy

  2025cites this paper
• Incisional Negative-Pressure Wound Therapy Versus Standard Dressing for the Prevention of Surgical Site Complications Following Radical Cystectomy

  2025cites this paper
• Perioperative Chemotherapy in Bladder and Upper Tract Urothelial Carcinoma: Outcomes by Nodal Status and Lymphovascular Invasion

  2025cites this paper
• Association of rs2294008 (PSCA) Gene polymorphism in Urothelial Bladder Cancer of South Indian Population

  2025cites this paper
• Reclassification of pathologically upstaged T3a Renal Cell Carcinoma is associated with enhanced alignment of outcomes: Analysis of the National Cancer Database.

  2025cites this paper
• Significance of split-dose cisplatin-based neoadjuvant chemotherapy followed by robotic-assisted radical cystectomy for muscle invasive bladder cancer

  2025cites this paper
• Clinical value of combining epirubicin with mindfulness intervention in patients with urinary system tumors and depression

  2025cites this paper
• Node-RADS category on preoperative CT predicts prognosis in patients with papillary renal cell carcinoma

  2025cites this paper
• Dysregulation of LYN Gene Expression in Melanoma Patients: A Statistically Significant Association with Clinical Outcomes

  2025cites this paper
• Assessing the Attention Layers in Convolutional Neural Networks for Penile Cancer Detection in Histopathological Images

  2025cites this paper
• The comparison of outcomes between neoadjuvant novel and classical hormonal therapy in patients with locally advanced prostate cancer: a retrospective study

  2025cites this paper
• Analysis of incidental prostate acinar adenocarcinoma: a single-center retrospective study

  2025cites this paper
• Deep learning-based survival analysis of bladder cancer patients in the Putuo District, Shanghai, China

  2025cites this paper
• Oncological outcomes and complications following radical cystectomy with or without neoadjuvant chemotherapy – A retrospective comparative cohort study from a single-center in South India

  2025cites this paper
• Single-cell stemness analysis highlights Midkine-LRP1 pathway and identifies new bladder cancer subtypes

  2025cites this paper
• Risk factors for rectal wall infiltration in hydrogel spacer placement: Influence of biopsy approach

  2025cites this paper
• AI-based prediction of androgen receptor expression and its prognostic significance in prostate cancer

  2025cites this paper
• Urinary DNA Methylation Test for Bladder Cancer Diagnosis.

  2025cites this paper
• External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study

  2025cites this paper
• Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy

  2025cites this paper
• Testicular Germ Cell Tumors: A Review.

  2025cites this paper
• The Performance and Role of PSMA PET Scans in Localised Prostate Cancer

  2025cites this paper
• Extravasation of enfortumab vedotin: a case report and literature review on antibody-drug conjugates

  2025cites this paper
• Risk Factors of Preoperative Renal Dysfunction and Its Impact on Survival in Patients with Renal Tumor and Inferior Vena Cava Tumor Thrombus

  2025cites this paper
• Contemporary outcomes for robotic radical cystectomy and intracorporeal neobladder urinary diversion.

  2025cites this paper
• The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est)

  2025cites this paper
• Artificial intelligence-based multimodal prediction for nuclear grading status and prognosis of clear cell renal cell carcinoma: a multicenter cohort study

  2025cites this paper
• Interpretable Machine Learning Radiomics Model Predicts 5-year Recurrence-Free Survival in Non-metastatic Clear Cell Renal Cell Carcinoma: A Multicenter and Retrospective Cohort Study.

  2025cites this paper
• Impact of the COVID‐19 Pandemic on Prostate Cancer: Perturbations in Screening and Diagnostic Patterns

  2025cites this paper
• Adenosquamous cell carcinoma of the penis: a case report and literature review

  2025cites this paper
• Management of Advanced Penile Cancer

  2025cites this paper
• The Significance of Circulating Basophils as Predictors of Tumor Aggressiveness in Clear‐Cell Renal Cell Carcinoma

  2025cites this paper
• Predicting prostate adenocarcinoma patients’ survival and immune signature: a novel risk model based on telomere-related genes

  2024cites this paper
• Development and evaluation of a disulfidoptosis-related lncRNA index for prognostication in clear cell renal cell carcinoma

  2024cites this paper
• Deep Convolutional Neural Network-Based Model for Precise Grading and Diagnosis of Bladder Cancer from Pathological Images

  2024cites this paper
• The value of urinary exosomal microRNA‐21 in the early diagnosis and prognosis of bladder cancer

  2024cites this paper
• Partial nephrectomy after a period of active surveillance: Are perioperative and pathology outcomes worsened compared to immediate surgery?

  2024cites this paper
• Predicting positive surgical margins in patients treated with robot-assisted partial nephrectomy: results from a prospectively maintained dataset of a single tertiary referral center

  2024cites this paper
• The 2012 Briganti nomogram predicts disease progression after surgery in high-risk prostate cancer patients

  2024cites this paper
• Competing risk nomogram predicting cause-specific mortality in older patients with testicular germ cell tumors

  2024cites this paper
• The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2b

  2024cites this paper
• Value of Flemish Version of the Triage Risk Screening Tool in Predicting Unfavorable Outcomes after Elective Cancer Surgery: A Propensity Score-Matched Retrospective Cohort Study

  2024cites this paper
• Development of a machine learning-based predictive model for transitional cell carcinoma of the renal pelvis in White Americans: a SEER-based study

  2024cites this paper
• Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75

  2024cites this paper
• Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes.

  2024cites this paper
• Impact of platelet-lymphocyte ratio after robot-assisted partial nephrectomy with renorrhaphy

  2024cites this paper
• N6-methyladenosine-modified SRD5A3, identified by IGF2BP3, sustains cisplatin resistance in bladder cancer

  2024cites this paper
• Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses

  2024cites this paper
• Histogram analysis of MR quantitative parameters: are they correlated with prognostic factors in prostate cancer?

  2024cites this paper
• Management of Bulky Inguinal and Pelvic Lymph Nodes.

  2024cites this paper
• Innovative Therapies Targeting Drug-Resistant Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)

  2024cites this paper
• Challenges and technical aspects in the management of muscle invasive bladder cancer as retrograde radical cystectomy with ileal conduit.

  2024cites this paper
• The Added-value of Staging 18F-FDG PET/CT in the Prediction of Overall Survival in the Patients with Bladder Cancer

  2024cites this paper
• FGFR3 Mutations in Urothelial Carcinoma: A Single-Center Study Using Next-Generation Sequencing

  2024cites this paper
• A dynamic visualization clinical tool constructed and validated based on the SEER database for screening the optimal surgical candidates for bone metastasis in primary kidney cancer

  2024cites this paper
• Value of Cystatin C-Based Sarcopenia Index in Patients Undergoing Surgery for Renal Tumors.

  2024cites this paper
• Housework participation and mortality in Japanese male patients undergoing cancer surgery: A propensity score-matched study.

  2024cites this paper
• Differentiation of Muscular Invasion in Bladder Cancer: Additional Value of Synthetic Magnetic Resonance Imaging.

  2024cites this paper
• Prognostic impact of tumor size in ureteral cancer following segmental ureterectomy.

  2024cites this paper
• Comparing Preoperative Screening Tools for Elective Urologic Cancer Surgery: Insights from a Cluster Analysis

  2024cites this paper
• Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis

  2024cites this paper